We are a global family

Bayer supports new PVRI 2027 Early Career Travel Awards

Bayer supports new travel awards to help early-career delegates from across the world attend the PVRI 2027 Congress in Bangkok. Applications are now open and close on 25 November 2026, 09:00 GMT.

More info & apply here

Southeast Asia Task Force relaunches

Our Southeast Asia Task Force was re-established in September 2026 to strengthen collaboration across the region and support locally led efforts to improve PH care, research, education, and advocacy.

Find out more

Sri Lanka Launches New Joint Clinical Statement

Sri Lanka takes a major step forward in PH care with a new joint clinical statement. The Sri Lanka Task Force members helped develop the statement through a collaborative effort, and it was presented during the Sri Lanka College of Cardiology Annual Academic Sessions 2026.

Learn more

Sri Lanka College of Cardiology Annual Academic Sessions 2026

Global PH Consult

Submit an anonymised complex PH case for discussion with a tailored panel of specialists. The free service is open to clinicians worldwide, with a particular focus on supporting those in LMICs and strengthening shared learning across the global PH community.

Submit your case

Featured events

PVRI 2027 Bangkok

27 January 2027

LATE -BREAKING ABSTRACT PORTAL OPEN! Closes 30 November, 09:00 GMT

Join us for an interactive, future-focused Congress bringing together the global PH community. Hosted in the heart of Asia, it will explore the latest in PH science, innovation, and care, with sessions spanning AI, omics, precision medicine, and much more.

Apply for our Bayer-supported early career travel awards to attend our Bangkok 2027 meeting. Deadline: 25 November 2026, 09:00 GMT

Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights

12 November 2026

Discover emerging blood biomarkers that could improve risk assessment, clinical validation, and outcome prediction in pulmonary arterial hypertension. Leading experts will share new insights into proteomics, NOTCH3-ECD, oxysterol and bile acid synthesis, endostatin, and vascular dysfunction.

Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise

17 November 2026

Part of the 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series by the High Altitude Task Force, who raise awareness and understanding of PH linked to high altitude and organise scientific conferences in regions affected by high altitudes.

Women's Health Career Pathways: Jessica Badlam

19 November 2026

Join Jessica Badlam for the first webinar in the 'Women's Health Career Pathways' series. Discover the experiences, collaborations, and career decisions that shaped her journey in women's health and PH research, with practical insights on mentorship, leadership, and professional growth.

Featured learning and research

Pulmonary Hypertension Community Call — October

In this Call, Dr. Tyler Couch discusses using chest CT to assess pulmonary artery dilation across chronic lung diseases and its correlation with PH. Dr. Agustin Garcia Roca details how CT vessel metrics characterise pulmonary vascular abnormalities and severe PH in COPD and fibrosing ILD. Dr. Olympia Bikou presents her study on microRNA-224 (miR-224) as a therapeutic target for PH, demonstrating its role in smooth muscle cell proliferation and the ameliorating effects of its inhibition on vascular remodelling and right heart function.

Pulmonary Circulation, Volume 16, Issue 4 — bi-weekly round up

A round-up of articles published in PVRI's Pulmonary Circulation journal between 21 - 29 October 2026

4D-Flow MRI-Derived Wall Shear Stress as a Non-Invasive Biomarker for the Detection and Hemodynamic Characterization of Pulmonary Hypertension

Invasive right heart catheterization (RHC) remains the reference standard for diagnosing pulmonary hypertension (PH), but there is a pressing need for non-invasive techniques to assess pulmonary hemodynamics. This study evaluates 4D-flow MRI-derived wall shear stress (WSS) for PH detection using the updated 2022 hemodynamic criteria, and the prediction of right ventriculo-pulmonary arterial (RV-PA) uncoupling to assess disease severity.

Identifying a Cardio-Hepatic Phenotype by Integrating the Albumin-Bilirubin Score Into Risk Assessment in Pulmonary Arterial Hypertension

Risk stratification is essential in pulmonary arterial hypertension (PAH), yet the prognostic utility of the albumin-bilirubin (ALBI) score as a marker of hepatic dysfunction remains underexplored. In this single-center study, we evaluated the clinical, neurohumoral, echocardiographic and hemodynamic correlates and prognostic value of the ALBI score, and to assess whether this score offers an incremental benefit over the Registry to EValuate Early And Long-term pulmonary arterial hypertension disease management (REVEAL) 2.0 risk score in patients with PAH.

News

Bayer supports NEW travel awards for early-career delegates

We are delighted to launch a further round of early career travel awards for our Bangkok 2027 meeting, kindly supported by Bayer.

Understanding PH Care in Southeast Asia

In May 2026, PVRI began exploring how we can strengthen PH collaboration across Southeast Asia. To understand the regional landscape and hear directly from those working in PH, we launched a survey alongside a wider mapping exercise, inviting healthcare professionals, researchers and other stakeholders to share their experiences and priorities.

PVRI welcomes Rachel Arrundale as a Trustee

We are delighted to welcome Rachel Arrundale to the PVRI Board of Trustees — Rachel brings more than 30 years’ experience in health policy, regulation, international development and organisational governance.

Nominations open for PVRI President 2028-30 & PVRI Achievement Awards 2026

We are delighted to announce that nominations are now open for both the PVRI President 2028-30 and PVRI Achievement Awards 2026.

These nominations provide an opportunity to recognise outstanding contributions to PH research, care and collaboration, and to help shape the future leadership of PVRI.